Financing, Equity Capital Markets

Tourmaline Bio

01/24
|
$172.4 Million
Tourmaline Bio
Piper Sandler served as bookrunner for Tourmaline Bio, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma